Stock Analysis

innoscripta Reports Second Quarter 2025 Earnings

Advertisement

innoscripta (ETR:1INN) Second Quarter 2025 Results

Key Financial Results

  • Net income: €5.06m (up by €5.06m from 2Q 2024).
  • EPS: €0.51.
earnings-and-revenue-growth
XTRA:1INN Earnings and Revenue Growth August 25th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

innoscripta Earnings Insights

Looking ahead, revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Germany.

Performance of the German Software industry.

The company's shares are up 5.1% from a week ago.

Risk Analysis

Be aware that innoscripta is showing 1 warning sign in our investment analysis that you should know about...

Valuation is complex, but we're here to simplify it.

Discover if innoscripta might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.